![Richard D. Katz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard D. Katz
Geen lopende functies
Profiel
Richard D.
Katz served as CFO, Executive VP-Finance & Corporate Development at Neusentis, Inc. He also held the position of Chief Financial Officer at Liquidia Technologies, Inc., Icagen, Inc., and Argos Therapeutics, Inc. Additionally, he was the Chief Financial & Business Officer at Viamet Pharmaceuticals, Inc. and Viamet Pharmaceuticals Corp.
Prior to these roles, he worked as a Vice President at Goldman Sachs & Co. LLC.
Katz holds an undergraduate degree from Harvard University, a doctorate from Stanford University School of Medicine, and an MBA from Harvard Business School.
Eerdere bekende functies van Richard D. Katz
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 02-09-2022 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Financieel Directeur/CFO | 20-08-2020 |
| LIQUIDIA CORPORATION | Financieel Directeur/CFO | 01-08-2020 |
| ARGOS THERAPEUTICS, INC. | Financieel Directeur/CFO | 30-11-2018 |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Financieel Directeur/CFO | 01-05-2016 |
Opleiding van Richard D. Katz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
28
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Icagen, Inc.
 Icagen, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical and drug discovery instruments | Health Technology |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Allena Pharmaceuticals, Inc.
 Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies MarketScreener 
